EMMAOTCPharmaceutical PreparationsFiscal year ends December 31
Emmaus Life Sciences, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.05−0.01 (-14.38%)
Close on Oct 19, 2026
- Market cap
- $6.03M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Jul 18, 2019 | 1-for-6 reverse | Earlier per-share figures multiplied by 6 |
| Dec 22, 2016(first seen in filings) | 1-for-200 reverse | Earlier per-share figures multiplied by 200 |
| Sep 21, 2016 | 1-for-200 reverse | Earlier per-share figures multiplied by 200 |
| May 15, 2012(first seen in filings) | 1-for-30 reverse | Earlier per-share figures multiplied by 30 |
| Apr 3, 2012 | 1-for-30 reverse | Earlier per-share figures multiplied by 30 |